April 3, 2023
Company name:Name of representative:
Inquiries:

FINDEX Inc.
Teruo Aibara, President & CEO(Securities code: 3649; PRIMEMarket)
Takashi Murakami, Finance &Investor Relations, Business Strategy(Telephone: +81-3-6271-8958)

Notice of Changes in Organizational Structure and Assignments of Officers
FINDEX Inc. (the "Company") hereby announces the changes in its organizational structure and assignments ofOfficers effective on April 1, 2023. The Directors were duly approved at the 38th General Meeting of Shareholders
held on March 28, 2023.
1.

Changes in Organizational Structurea) Split of System Development Department
The “System Development Department” has now been divided into “Software Package Development,”
which handles development and improvement of existing products, and “Product Planning &Development,” which is responsible for planning and development of new solutions.
【Software Package Development】
This department specializes in development of packaged medical software used in large hospitals, andstandardization and implementation of medical data and electronic medical record, improving andupgrading the Company’s core product “Claio”, as well as other packaged solutions that have already beenmarketed.
【Product Planning & Development】
This department specializes in development of infrastructural technologies to support digitaltransformation in medical industry, as well as in developing cloud-based products that form a new
outpatient care system, connecting patients and hospitals. The team will be developing new products andservices to meet future demands.
b) Establishment of a new department for customer support【Customer Support Department】
Customer Support Department, a new spinoff from “Medical Solutions Department”, is a teamresponsible for handling inquiries from customers, mainly the clinics. The team is dedicated tosupport challenges of their customers in complying the domestic medical fee regulations, or toprovide cyber security solutions.

c) Change in the scope of responsibilities in the Administration Department
The Company's Administration Department was previously responsible for legal, humanresources, accounting, finance, and investor relations all together, but finance and investor relations
are transferred to the Business Strategy Department, to decentralize these operations and strengthen
the function of each business unit.
2.

Changes in Assignments of Officers
Directors（effective on April 1, 2023）
Title
NamePresident & CEODirectorTeruo Aibara
Kohji Kondo

Director

Hiroaki Hasegawa

Director

Riki Miyakawa

DirectorDirector
Director

Akira Ono
Kouji Yamauchi
Takashi Kitada

Director

Akira Yamada

Corporate Officers（effective on April 1, 2023）
Title
Name
Corporate Officer
Corporate Officer（New）

Keisuke Kakiuchi
Atsushi Fujita

Corporate Officer（New）
Corporate Officer

Takashi Murakami
Hideaki Mochiduki

Responsibilities
Business Strategy Department
Department Manager of Medical Sales Solutions, andSupervisor of Health Tech Business
Department Manager of Consulting, and Supervisorof Public Sector Solutions
Department Manager of Software Package
Development, and Supervisor of Medical BusinessOutside Director
Audit & Supervisory Committee（Full-Time）
Outside Director, Audit & Supervisory Committee(Part-Time)
Outside Director, Audit & Supervisory Committee(Part-Time)

Responsibilities
Department Manager of Hospital Sales Solutions
Department Manager of Administration, Legal,
Human Resources, and Accounting
Finance & Investor Relations
Department Manager of Product Planning &Development

【Reference：Organizational Chart （As of April 3, 2023）】（Underlined are the changes）

Note: This is a translation of the document originally prepared in Japanese. In the event of any discrepancies inwords or the like between this document and the original, the original Japanese version shall govern.